Outcome Comparison of Two Total Knee Arthroplasty Systems: e.Motion-Pro Versus Genesis II
Comparisons of Prosthesis Fitness, Early Recovery Patterns, Functional Outcomes and Patient Satisfaction Between E.Motion-Pro, a New Mobile Bearing System and Genesis II, an Established Successful System
1 other identifier
interventional
300
1 country
1
Brief Summary
Recently, E.Motion-PS-Pro (B.Braun-Aesculap, Tuttlingen, Germany), a new mobile bearing knee system with a unique ball and socket post-cam mechanism was developed for use in total knee arthroplasty. This study aims to determine (1) whether the use of E.Motion-PS-Pro improves prosthesis fitness for the femur and tibia in terms of under- or over-hang incidence compared to an established successful prosthesis, Genesis II (Smith \& Nephew, Memphis, U.S.A.), (2) whether patients with this new prosthesis experience less pain and faster wound healing in early recovery phase, (3) whether patients with E.Motion-Pro reach functional plateaus faster than patients with Genesis II and the functional plateaus of patients with E.Motion-Pro are higher than those of patients with Genesis II.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2014
CompletedFirst Submitted
Initial submission to the registry
October 19, 2014
CompletedFirst Posted
Study publicly available on registry
October 27, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedOctober 27, 2014
July 1, 2014
1 year
October 19, 2014
October 23, 2014
Conditions
Outcome Measures
Primary Outcomes (5)
prosthesis fit
Component fitness will be evaluated by whether there is overhang (too wide or big) or underhang (too narrow or small) more than 2 mm at any of three sites: condyle, junction, and anterior flange
from the start to end of surgery (expected average of 90 minutes)
pain level during gait at 3 months after surgery
Pain levels will be evaluated by asking how much pain patients feel during weight bearing gait at 3 months in 0-10 visual analog scale (0-no pain and 10-maximum pain)
at 3 months after surgery
knee swelling (circumference measured at the knee) at 3 months
Knee swelling will be evaluated by measuring the leg circumference at the knee level (mid-patella), and the measured circumference will be compared with the preoperative circumference
at 3 months after surgery
flexion contracture and maximum flexion at 3 months
Flexion contracture and further flexion will be measured by a single investigator using a 38-cm clinical goniometer with patients supine
at 3 months after surgery
the new American Knee Society (AKS) score at 6 months
Patients will be evaluated at 6 months using the new scoring system of American Knee Society. The American Knee Society scoring system evaluates multiple aspects of outcomes: 1) Objective knee indicators (maximum points 80) - alignment (25), mediolateral (ML) stability (15), anteroposterior (AP) stability (10), range of motion (ROM) (30); 2) Knee score (maximum points 80) - symptoms (25), patient satisfaction (40), and expectation (15); 3) Function score (maximum points 100) - walking \& standing (30), standard activities (30), advanced activities (25), discretionary knee activities (15)
at 6 months after surgery
Secondary Outcomes (10)
whether balanced gaps were achieved
from the start to end of surgery (expected average of 90 minutes)
tourniquet time
from the start to end of surgery (expected average of 90 minutes)
blood volume drained via a vacuum drainage in the subcutaneous tissue
from the end of surgery to removal of vacuum drainage (usually at 2 days after surgery)
hemoglobin drop on postoperative 2 and 5 days
at 2 and 5 days after surgery
pain level during motion arc exercise at 2 and 6 weeks
at 2 and 6 weeks after surgery
- +5 more secondary outcomes
Study Arms (2)
e.motion PS Pro group
EXPERIMENTALthe patients who receives total knee arthroplasty with the e.motion PS pro prosthesis
Genesis II group
ACTIVE COMPARATORthe patients who receives total knee arthroplasty with the Genesis II prosthesis
Interventions
patients will undergo total knee arthroplasty with e.motion PS Pro implant
patients will undergo total knee arthroplasty with Genesis II implant
Eligibility Criteria
You may qualify if:
- patients who are decided to undergo total knee arthroplasty with diagnosis of primary osteoarthritis
You may not qualify if:
- the diagnosis other than primary osteoarthritis
- previous history of infection or trauma requiring surgical treatment on the knee which will receive total knee arthroplasty
- patients of 80 years or older
- patients with systemic diseases that can affect functional outcomes of TKA
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Joint Reconstruction Center, Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 463-707, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Tae Kyun Kim, MD, PhD
Seoul National University Bundang Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 19, 2014
First Posted
October 27, 2014
Study Start
July 1, 2014
Primary Completion
July 1, 2015
Study Completion
December 1, 2015
Last Updated
October 27, 2014
Record last verified: 2014-07